Update: Why Diabetes Does Not Resolve in Some Patients after Bariatric Surgery
- Mervyn Deitel
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Bariatric surgery provides resolution of co-morbidities of morbid obesity—importantly diabetes type 2. This is initiated by immediate postoperative decrease in intake or assimilation of glucose and is continued by the substantial loss of adipose tissue. Greater weight loss and greater resolution of type 2 diabetes occur after operations that provide rapid passage of nutrients to the hindgut, which likely results in beta-cell stimulation by incretins. Failure of resolution of the diabetes can result from lack of patient compliance, inadequate weight loss, longstanding uncontrolled diabetes, or when the diabetes is actually a type 1.
- Sanderson I, Deitel M, Bojm MA. The handling of glucose and insulin response before and after weight loss with jejuno-ileal bypass. JPEN J Parenter Enteral Nutr. 1983;7:274–6. CrossRef
- Deitel M, Sidhu PS, Stone E. Effect of vertical banded gastroplasty on diabetes in the morbidly obese. Obes Surg. 1991;1:113–4. abst.
- Sanderson I, Deitel M. Insulin response in patients receiving concentrated infusions of glucose and casein hydrolysate for complete parenteral nutrition. Ann Surg. 1974;179:387–94. CrossRef
- Keith SJ, Mason EE, Scott DH, et al. Serum insulin and glucose levels, and insulin binding kinetics, in morbid and super obese patients undergoing vertical banded gastroplasty. Obes Surg. 1991;1:112. abst.
- Gumbs AA, Modlin AM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462–73. CrossRef
- Burstein R, Epstein Y, Charuzi I, et al. Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation. Int J Obes. 1995;19:558–61.
- Mingrone G, DeGaetano A, Greco AV, et al. Reversability of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia. 1997;40:599–605. CrossRef
- Türkoglu C, Duman BS, Güney D, et al. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Obes Surg. 2003;13:699–705. CrossRef
- Näslund E, Backman L, Holst JJ, et al. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg. 1998;8:253–60. CrossRef
- Mason EE. Gastric emptying controls type 2 diabetes mellitus (editorial). Obes Surg. 2007;17:853–5. CrossRef
- Valverde I, Puente J, Martin-Duce A, et al. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg. 2005;15:387–97. CrossRef
- le Roux CW, Dixon JB. Metabolic syndrome and type 2 diabetes: GLP-1 and other incretins. In: Deitel M, Gagner M, Dixon JB, et al., editors. Handbook of Obesity Surgery. Toronto: FD-Communications; 2010. p. 298–303.
- Reinehr T, Roth CL, Schernthaner G-H, et al. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes Surg. 2007;17:1571–7. CrossRef
- Melissas J, Daskalakis M, Koukouraki S, et al. Sleeve gastrectomy—a “food-limiting” operation. Obes Surg. 2008;18:1251–6. CrossRef
- Karamanakos SN, Vagenes K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double-blind study. Ann Surg. 2008;247:401–7. CrossRef
- Shah S, Shah P, Todkar J, et al. Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6:152–7. CrossRef
- Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6:254–9. CrossRef
- DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6:249–53. CrossRef
- Hall TC, Pellen MGC, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20:1245–50. CrossRef
- Hamza N, Abbas MH, Darwish A, et al. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 2010 epub (In press).
- Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1004–10. CrossRef
- Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;229:316–23. CrossRef
- Deitel M. Surgery for diabetes at lower BMI: some caution (editorial). Obes Surg. 2008;18:1211–4. CrossRef
- Betterle C, Zanette F, Kawasaki E, et al. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first degree relatives. Diabetologia. 1983;26:431–6.
- Zimmet P, Turner R, McCarty D, et al. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diab Care. 1999;22 Suppl 2:B59–64.
- Seisser J. Latent (slowly progressing) autoimmune diabetes in adults. Curr Diab Rep. 2008;8:94–100. CrossRef
- Landin-Olsson M. Latent autoimmune diabetes in adults. Ann NY Acad Sci. 2002;958:112–6. Apr. CrossRef
- Rosario PW, Reis JS, Fagundes TA, et al. Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization. Arq Bras Endocrinol Metabol. 2007;51:52–8. CrossRef
- Brophy S, Yderstraede K, Mauricio D, et al. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diab Care. 2008;31:439–41. CrossRef
- Murao S, Kondo S, Ohashi J, et al. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)—5-year follow-up of the Ehime study. Diab Res Clin Pract. 2008;80:114–21. CrossRef
- Gagner M, Deitel M, Kalberer BA, et al. The Second International Consensus Summit for Sleeve Gastrectomy Mar 19–21, 2009. Surg Obes Relat Dis. 2009;5:476–85. CrossRef
- Czupryniak L, Wiszniewski M, Szymanski D, et al. Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg. 2010;20:506–8. CrossRef
- Update: Why Diabetes Does Not Resolve in Some Patients after Bariatric Surgery
Volume 21, Issue 6 , pp 794-796
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Morbid obesity
- Type 2 diabetes
- Type 1 diabetes
- Bariatric surgery
- Industry Sectors
- Mervyn Deitel (1)
- Author Affiliations
- 1. Editor-in-Chief Emeritus and Founding Editor, Obesity Surgery, 39 Bassano Road, Toronto, ON, M2N 2J9, Canada